Pharma is getting serious about gene therapy, one-time treatments that alter genes to cure devastating diseases. BIPrime
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pharma giant Roche just bought biotech firm Spark, the maker of an $850,000 eye drugRoche is set to buy gene therapy firm Spark Therapeutics for about $4.8 billion. Spark's stock more than doubled in premarket trading.
Baca lebih lajut »
‘It’s finally pharma’s turn’: Drug CEOs face Capitol Hill reckoningSeven drugmakers will be grilled over high prices at a hearing this week, in what could be a watershed moment for the industry.
Baca lebih lajut »
GE-Danaher pharma deal is a win-win remedyCEO Larry Culp is unloading the conglomerate’s biologics unit to his old employer for $21 bln. It’s his boldest downsizing move yet and will help cut leverage. Danaher gains scale in its health business at a reasonable price while Culp needed a sale, not necessarily top dollar.
Baca lebih lajut »
U.S. Hate Groups Rose 30 Percent In Recent Years, Watchdog Group ReportsThe Southern Poverty Law Center says many groups are driven by white supremacist ideology and the 'hysteria over losing a white-majority nation.' Critics accuse the group of overblowing the threat.
Baca lebih lajut »
Jobless claims sink 23,000 to 216,000 - recent spike appears to be false alarmThe number of people who applied for jobless benefits in mid-February fell sharply and returned near recent postrecession lows, suggesting the U.S. labor market is still going strong and keeping the economy on a firm footing. Jobless claims fell by 23,000 to 216,000.
Baca lebih lajut »